Panel Discussion – Assessing Potential Outcomes for the Adenosine Field in the Event of An Approval Or Major Failure

Time: 9:00 am
day: Day One


  • Discuss how energy will be best placed in the event of a successful clinical result to capitalize on investment and renewed interest the field will receive
  • Consider potential outcomes for the space if multiple clinical failures occur and contingency plans to ensure spent time is not wasted Discuss cancer types where the data currently hints that Adenosine will be most applicable
  • If immunotherapeutic applications become less realistic what opportunities should the field realistically consider outside of oncology